Charlie Kang

Charlie Kang

Charlie Kang


Charlie Kang was with Johnson & Johnson where he led Business Development for the DePuy Synthes Biologics business unit. Prior to J&J, Charlie held senior Strategy and Business Development roles at Synthes, Aspen Biopharma, and Life Technologies. Charlie started his biotech career in R&D at Somatogen Inc. developing recombinant hemoglobin-based blood substitutes. Mr. Kang obtained his MBA and his Bachelors in Molecular, Cellular, and Developmental Biology from the University of Colorado.